-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOHAVEN SHARES DOWN 14.2% PREMARKET AFTER CO'S DEPRESSION DRUG FAILS MID-STAGE TRIAL

Reuters·12/26/2025 09:05:03

Please log in to view news